160 related articles for article (PubMed ID: 38632615)
1. DNA-based molecular classifiers for the profiling of gene expression signatures.
Zhang L; Liu Q; Guo Y; Tian L; Chen K; Bai D; Yu H; Han X; Luo W; Feng T; Deng S; Xie G
J Nanobiotechnology; 2024 Apr; 22(1):189. PubMed ID: 38632615
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Biomarker Identification Through Integrating the Gene Signatures of Hepatocellular Carcinoma Properties.
Cai J; Li B; Zhu Y; Fang X; Zhu M; Wang M; Liu S; Jiang X; Zheng J; Zhang X; Chen P
EBioMedicine; 2017 May; 19():18-30. PubMed ID: 28434945
[TBL] [Abstract][Full Text] [Related]
3. Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma.
Grinchuk OV; Yenamandra SP; Iyer R; Singh M; Lee HK; Lim KH; Chow PK; Kuznetsov VA
Mol Oncol; 2018 Jan; 12(1):89-113. PubMed ID: 29117471
[TBL] [Abstract][Full Text] [Related]
4. A microRNA expression profile for vascular invasion can predict overall survival in hepatocellular carcinoma.
Lin Z; Cai YJ; Chen RC; Chen BC; Zhao L; Xu SH; Wang XD; Song M; Wu JM; Wang YQ; Zhou MT; Shi KQ
Clin Chim Acta; 2017 Jun; 469():171-179. PubMed ID: 28365450
[TBL] [Abstract][Full Text] [Related]
5. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
6. A systems biology-based classifier for hepatocellular carcinoma diagnosis.
Zhang Y; Wang S; Li D; Zhnag J; Gu D; Zhu Y; He F
PLoS One; 2011; 6(7):e22426. PubMed ID: 21829460
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a new tumor-based gene signature predicting prognosis of HBV/HCV-included resected hepatocellular carcinoma patients.
Zhu GQ; Yang Y; Chen EB; Wang B; Xiao K; Shi SM; Zhou ZJ; Zhou SL; Wang Z; Shi YH; Fan J; Zhou J; Liu TS; Dai Z
J Transl Med; 2019 Jun; 17(1):203. PubMed ID: 31215439
[TBL] [Abstract][Full Text] [Related]
8. The clinical implications of G1-G6 transcriptomic signature and 5-gene score in Korean patients with hepatocellular carcinoma.
Ahn SM; Haq F; Park I; Nault JC; Zucman-Rossi J; Yu E
BMC Cancer; 2018 May; 18(1):571. PubMed ID: 29776391
[TBL] [Abstract][Full Text] [Related]
9. Cancer-Testis Gene Expression in Hepatocellular Carcinoma: Identification of Prognostic Markers and Potential Targets for Immunotherapy.
Zhang YP; Bao ZW; Wu JB; Chen YH; Chen JR; Xie HY; Zhou L; Wu J; Zheng SS
Technol Cancer Res Treat; 2020; 19():1533033820944274. PubMed ID: 32715976
[TBL] [Abstract][Full Text] [Related]
10. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
11. A Novel Epigenetic Machine Learning Model to Define Risk of Progression for Hepatocellular Carcinoma Patients.
Bedon L; Dal Bo M; Mossenta M; Busato D; Toffoli G; Polano M
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499054
[TBL] [Abstract][Full Text] [Related]
12. A molecular multi-gene classifier for disease diagnostics.
Lopez R; Wang R; Seelig G
Nat Chem; 2018 Jul; 10(7):746-754. PubMed ID: 29713032
[TBL] [Abstract][Full Text] [Related]
13. A signature of 33 immune-related gene pairs predicts clinical outcome in hepatocellular carcinoma.
Sun XY; Yu SZ; Zhang HP; Li J; Guo WZ; Zhang SJ
Cancer Med; 2020 Apr; 9(8):2868-2878. PubMed ID: 32068352
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive molecular and immunological characterization of hepatocellular carcinoma.
Shimada S; Mogushi K; Akiyama Y; Furuyama T; Watanabe S; Ogura T; Ogawa K; Ono H; Mitsunori Y; Ban D; Kudo A; Arii S; Tanabe M; Wands JR; Tanaka S
EBioMedicine; 2019 Feb; 40():457-470. PubMed ID: 30598371
[TBL] [Abstract][Full Text] [Related]
15. Integrative analysis of DNA methylation and gene expression reveals distinct hepatocellular carcinoma subtypes with therapeutic implications.
Huang X; Yang C; Wang J; Sun T; Xiong H
Aging (Albany NY); 2020 Mar; 12(6):4970-4995. PubMed ID: 32201399
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic molecular markers in hepatocellular carcinoma.
MÃnguez B; Lachenmayer A
Dis Markers; 2011; 31(3):181-90. PubMed ID: 22045404
[TBL] [Abstract][Full Text] [Related]
17. Transcription factors linked to the molecular signatures in the development of hepatocellular carcinoma on a cirrhotic background.
Motalebzadeh J; Eskandari E
Med Oncol; 2021 Sep; 38(10):121. PubMed ID: 34468893
[TBL] [Abstract][Full Text] [Related]
18. Characterization of long non-coding RNAs to reveal potential prognostic biomarkers in hepatocellular carcinoma.
Ma Y; Luo T; Dong D; Wu X; Wang Y
Gene; 2018 Jul; 663():148-156. PubMed ID: 29684484
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Cancer-Associated Fibroblast-Related Gene Signatures in Hepatocellular Carcinoma.
Dong W; Xie Y; Huang H
Front Endocrinol (Lausanne); 2022; 13():884777. PubMed ID: 35733776
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel long non-coding RNAs deregulated in hepatocellular carcinoma using RNA-sequencing.
Esposti DD; Hernandez-Vargas H; Voegele C; Fernandez-Jimenez N; Forey N; Bancel B; Le Calvez-Kelm F; McKay J; Merle P; Herceg Z
Oncotarget; 2016 May; 7(22):31862-77. PubMed ID: 26887054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
